220 related articles for article (PubMed ID: 24204923)
1. Low-bone-mass phenotype of deficient mice for the cluster of differentiation 36 (CD36).
Kevorkova O; Martineau C; Martin-Falstrault L; Sanchez-Dardon J; Brissette L; Moreau R
PLoS One; 2013; 8(10):e77701. PubMed ID: 24204923
[TBL] [Abstract][Full Text] [Related]
2. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.
McGee-Lawrence ME; McCleary-Wheeler AL; Secreto FJ; Razidlo DF; Zhang M; Stensgard BA; Li X; Stein GS; Lian JB; Westendorf JJ
Bone; 2011 May; 48(5):1117-26. PubMed ID: 21255693
[TBL] [Abstract][Full Text] [Related]
3. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
4. Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation.
Xiao Z; Zhang S; Cao L; Qiu N; David V; Quarles LD
J Biol Chem; 2010 Jan; 285(2):1177-87. PubMed ID: 19887454
[TBL] [Abstract][Full Text] [Related]
5. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.
Yang JY; Cho SW; An JH; Jung JY; Kim SW; Kim SY; Kim JE; Shin CS
PLoS One; 2013; 8(2):e56585. PubMed ID: 23441207
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
[TBL] [Abstract][Full Text] [Related]
7. Gender- and region-specific alterations in bone metabolism in Scarb1-null female mice.
Martineau C; Martin-Falstrault L; Brissette L; Moreau R
J Endocrinol; 2014 Aug; 222(2):277-88. PubMed ID: 24928939
[TBL] [Abstract][Full Text] [Related]
8. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
9. The atherogenic Scarb1 null mouse model shows a high bone mass phenotype.
Martineau C; Martin-Falstrault L; Brissette L; Moreau R
Am J Physiol Endocrinol Metab; 2014 Jan; 306(1):E48-57. PubMed ID: 24253048
[TBL] [Abstract][Full Text] [Related]
10. Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation.
Tang J; Xie J; Chen W; Tang C; Wu J; Wang Y; Zhou XD; Zhou HD; Li YP
J Biol Chem; 2020 Aug; 295(33):11669-11681. PubMed ID: 32571873
[TBL] [Abstract][Full Text] [Related]
11. Effect of hypercortisolism on bone mineral density and bone metabolism: A potential protective effect of adrenocorticotropic hormone in patients with Cushing's disease.
Guo W; Li F; Zhu C; Wang B; Wang K; Dai C; Jia H; Wei H; He Q; Cui J; Yuan M; Tang S; Liu W; Zhu T; Gao Z; Zheng F; Ma Z; Qu H; Zhu M
J Int Med Res; 2018 Jan; 46(1):492-503. PubMed ID: 28851260
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast lineage-specific effects of notch activation in the skeleton.
Canalis E; Parker K; Feng JQ; Zanotti S
Endocrinology; 2013 Feb; 154(2):623-34. PubMed ID: 23275471
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of CD36 enhances injury after acute neonatal stroke.
Woo MS; Wang X; Faustino JV; Derugin N; Wendland MF; Zhou P; Iadecola C; Vexler ZS
Ann Neurol; 2012 Dec; 72(6):961-70. PubMed ID: 23280844
[TBL] [Abstract][Full Text] [Related]
14. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice.
Li M; Healy DR; Li Y; Simmons HA; Crawford DT; Ke HZ; Pan LC; Brown TA; Thompson DD
Bone; 2005 Jul; 37(1):46-54. PubMed ID: 15869929
[TBL] [Abstract][Full Text] [Related]
15. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
[TBL] [Abstract][Full Text] [Related]
16. Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model.
Triliana R; Lam NN; Sawyer RK; Atkins GJ; Morris HA; Anderson PH
J Steroid Biochem Mol Biol; 2016 Nov; 164():331-336. PubMed ID: 26343450
[TBL] [Abstract][Full Text] [Related]
17. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
18. Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis.
Lin SJ; Ho HC; Lee YF; Liu NC; Liu S; Li G; Shyr CR; Chang C
Reprod Biol Endocrinol; 2012 Jun; 10():43. PubMed ID: 22676849
[TBL] [Abstract][Full Text] [Related]
19. Skeletal development of mice lacking bone sialoprotein (BSP)--impairment of long bone growth and progressive establishment of high trabecular bone mass.
Bouleftour W; Boudiffa M; Wade-Gueye NM; Bouët G; Cardelli M; Laroche N; Vanden-Bossche A; Thomas M; Bonnelye E; Aubin JE; Vico L; Lafage-Proust MH; Malaval L
PLoS One; 2014; 9(5):e95144. PubMed ID: 24816232
[TBL] [Abstract][Full Text] [Related]
20. Matrix remodeling associated 7 promotes differentiation of bone marrow mesenchymal stem cells toward osteoblasts.
Zhou Z; Shen Y; Yin J; Xi F; Xu R; Lin D; Saijilafu ; Chen J; Wang Y
J Cell Physiol; 2019 Aug; 234(10):18053-18064. PubMed ID: 30843215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
